Lexadrine, or oxaliplatin for injection, is effective against colon cancer, with side effects such as diarrhea, nausea, and vomiting, and should be used in accordance with medical advice. Oxaliplatin for Injection can inhibit the replication and transcription of DNA and has anti-colon cancer effects. It is used in combination with 5-fluorouracil and formyltetrahydrofolate in the treatment of metastatic colorectal cancer as a first-line drug. To adjuvant treatment of primary tumor stage III colon cancer after complete resection. Visible adverse reactions to oxaliplatin for injection include diarrhea, nausea, vomiting, mucositis, neutropenia, thrombocytopenia, acute or dose-accumulative peripheral sensory neuropathy, injection site reactions, fever, fatigue, chills, anaphylactic reactions, weakness, pain, and weight gain. This product is contraindicated in hypersensitivity to oxaliplatin, hypersensitivity to other platinum compounds, and lactating women. Patients should regulate the use under the guidance of a doctor.